缺少EGR3可通过TLR4/NF-κB/TIMP-1轴缓解COPD中香烟烟雾引起的肺炎
Fang Zhang1, Yumei Geng2, Xuefeng Shi2
1Suzhou Medical College of Soochow University, No.199 Renai Road, Suzhou Industrial Park, Suzhou 215123, People's Republic of China; Department of Respiratory and Critical Care Medicine, Qinghai Provincial People's Hospital, No.2 Gonghe Road, Chengdong District, Xining 810000, People's Republic of China.
Biochemical and biophysical research communications
|April 12, 2025
概括
早期生长反应蛋白3 (EGR3) 促进慢性阻塞性肺病 (COPD) 的进展. 抑制EGR3改善了COPD小鼠模型中的肺功能和减少了炎症,这表明EGR3是治疗点.
科学领域:
- 免疫学和呼吸系统医学
- 疾病的分子机制.
背景情况:
- 慢性阻塞性肺病 (COPD) 的特点是不可逆转的气流限制和严重的气道炎症.
- 目前对COPD的诊断和治疗策略有限,特别是在疾病的早期阶段.
- 导致COPD相关的呼吸道炎症的确切机制尚未完全理解.
研究的目的:
- 研究早期生长反应3 (EGR3) 的作用,它是已知的适应性免疫的调节者,在COPD的发病过程中发挥作用.
- 探索EGR3作为潜在的治疗目标来治疗COPD.
主要方法:
- 使用了香烟烟雾引起的COPD的小鼠模型.
- 在经过6个月的烟雾暴露后,比较EGR3淘汰赛 (EGR3-/-) 小鼠与野生型 (WT) 小鼠.
- 评估肺功能,气道阻力,气膜结构和分子通路,包括TLR4/NF-κB和TIMP-1表达.
主要成果:
- 与WT小鼠相比,EGR3-/-小鼠表现出明显改善的肺功能和降低的呼吸道阻力.
- 在暴露于香烟烟雾的EGR3-/-小鼠中,膜结构损伤减弱.
- 缺少EGR3抑制了香烟烟雾诱导的TLR4/NF-κB通路的激活,并降低了肺组织和血清中的TIMP-1表达.
结论:
- 早期生长反应3 (EGR3) 作为COPD进展的新型促进剂.
- 通过EGR3介导的COPD促进涉及TLR4/NF-κB/TIMP-1信号轴.
- EGR3代表了潜在的COPD管理的诊断生物标志物和治疗目标.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
01:20COPD: Pathogenesis and Clinical Features
193
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
193
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.6K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.6K
01:26COPD: Management Using Bronchodilators and Corticosteroids
136
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
136
01:22Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K